Stratification of endometrioid endometrial cancer patients into risk levels using somatic mutations

Gynecologic Oncology

Volumn 142, Issue 1, 2016, Pages 150-157

  Dai, Donghai ^a   Thiel, Kristina W ^a   Salinas, Erin A ^a   Goodheart, Michael J ^a,b   Leslie, Kimberly K ^a,b   Gonzalez Bosquet, Jesus ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Endometrial cancer; Individualized treatment; Prediction model; Risk levels; Somatic mutations

Indexed keywords

ARMC4 PROTEIN; ARV1 PROTEIN; CCDC167 PROTEIN; CRYAB PROTEIN; CTDSPL2 PROTEIN; DCT PROTEIN; DDX49 PROTEIN; DISHEVELLED 1; DOCK3 PROTEIN; DOLK PROTEIN; FAM135A PROTEIN; LRRC17 PROTEIN; MAPK3 PROTEIN; MED13 PROTEIN; MT01 PROTEIN; NDUFAB1 PROTEIN; NFE2L1 PROTEIN; NUDT5 PROTEIN; P14KA PROTEIN; PDS4 PROTEIN; PGBD4 PROTEIN; PLAS3 PROTEIN; PROTEIN; RPS6KA1 PROTEIN; SDHAF2 PROTEIN; SMARCAL1 PROTEIN; TRANSCRIPTION FACTOR NFAT3; UNCLASSIFIED DRUG; UQCRC2 PROTEIN; WASF3 PROTEIN; ZMYND10 PROTEIN;

ARTICLE; CANCER RISK; CANCER STAGING; CANCER THERAPY; COMPARATIVE STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENDOMETRIOID ENDOMETRIAL CANCER; ENDOMETRIUM CANCER; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE IDENTIFICATION; HIGH RISK PATIENT; HUMAN; LOW RISK PATIENT; NEXT GENERATION SEQUENCING; PERSONALIZED MEDICINE; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SOMATIC MUTATION; AGED; BIOLOGICAL MODEL; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; EXOME; GENETIC SCREENING; GENETICS; HIGH THROUGHPUT SEQUENCING; MUTATION; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK;

AGED; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; EXOME; FEMALE; GENE FREQUENCY; GENETIC TESTING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MODELS, GENETIC; MUTATION; NEOPLASM STAGING; PRECISION MEDICINE; RETROSPECTIVE STUDIES; RISK; ROC CURVE;

EID: 84967316000     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2016.05.012     Document Type: Article

References (40)

1. R.L. Siegel, K.D. Miller, and A. Jemal Cancer statistics, 2015 Ca-a Cancer Journal for Clinicians 65 2015 5 29
2. W.T. Creasman, F. Odicino, P. Maisonneuve, M.A. Quinn, U. Beller, J.L. Benedet, and et al. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer Int J Gynaecol Obstet 95 Suppl. 1 2006 S105 S143
3. C.L. Creutzberg, W.L. van Putten, P.C. Koper, M.L. Lybeert, J.J. Jobsen, C.C. Warlam-Rodenhuis, and et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma Lancet 355 2000 1404 1411
4. ASTEC study group, H. Kitchener, A.M. Swart, Q. Qian, C. Amos, and M.K. Parmar Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study Lancet 373 2009 125 136
5. H.M. Keys, J.A. Roberts, V.L. Brunetto, R.J. Zaino, N.M. Spirtos, J.D. Bloss, and et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study Gynecol. Oncol. 92 2004 744 751
6. Endometrial cancer. Practice Bulletin No. 149 Obstet. Gynecol. 125 2015 1006 1026
7. J.L. Walker, M.R. Piedmonte, N.M. Spirtos, S.M. Eisenkop, J.B. Schlaerth, R.S. Mannel, and et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2 J. Clin. Oncol. 27 2009 5331 5336
8. A.B. Kornblith, H.Q. Huang, J.L. Walker, N.M. Spirtos, J. Rotmensch, and D. Cella Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group study J. Clin. Oncol. 27 2009 5337 5342
9. M. Janda, V. Gebski, A. Brand, R. Hogg, T.W. Jobling, R. Land, and et al. Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial Lancet Oncol 11 2010 772 780
10. P. Benedetti Panici, S. Basile, F. Maneschi, A. Alberto Lissoni, M. Signorelli, G. Scambia, and et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial J. Natl. Cancer Inst. 100 2008 1707 1716
11. S.C. Dowdy, B.J. Borah, J.N. Bakkum-Gamez, A.L. Weaver, M.E. McGree, L.R. Haas, and et al. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer Gynecol. Oncol. 127 2012 5 10
12. Y. Todo, K. Okamoto, M. Hayashi, S. Minobe, E. Nomura, H. Hareyama, and et al. A validation study of a scoring system to estimate the risk of lymph node metastasis for patients with endometrial cancer for tailoring the indication of lymphadenectomy Gynecol. Oncol. 104 2007 623 628
13. A. Mariani, M.J. Webb, G.L. Keeney, M.G. Haddock, G. Calori, and K.C. Podratz Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am. J. Obstet. Gynecol. 182 2000 1506 1519
14. T. Hidaka, A. Nakashima, T. Shima, T. Hasegawa, and S. Saito Systemic lymphadenectomy cannot be recommended for low-risk corpus cancer Obstet. Gynecol. Int. 2010 2010 490219
15. W.T. Creasman, C.P. Morrow, B.N. Bundy, H.D. Homesley, J.E. Graham, and P.B. Heller Surgical pathologic spread patterns of endometrial cancer A Gynecologic Oncology Group Study. Cancer 60 1987 2035 2041
16. M.M. AlHilli, and A. Mariani Preoperative selection of endometrial cancer patients at low risk for lymph node metastases: useful criteria for enrollment in clinical trials J. Gynecol. Oncol. 25 2014 267 269
17. A. Mariani, S.C. Dowdy, W.A. Cliby, B.S. Gostout, M.B. Jones, Wilson TO, and et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging Gynecol. Oncol. 109 2008 11 18
18. P.A. Convery, L.A. Cantrell, N. Di Santo, G. Broadwater, S.C. Modesitt, A.A. Secord, and et al. Retrospective review of an intraoperative algorithm to predict lymph node metastasis in low-grade endometrial adenocarcinoma Gynecol. Oncol. 123 2011 65 70
19. T. Mitamura, H. Watari, Y. Todo, T. Kato, Y. Konno, M. Hosaka, and et al. Lymphadenectomy can be omitted for low-risk endometrial cancer based on preoperative assessments J. Gynecol. Oncol. 25 2014 301 305
20. C.G.A.R. Network, C. Kandoth, N. Schultz, A.D. Cherniack, R. Akbani, Y. Liu, and et al. Integrated genomic characterization of endometrial carcinoma Nature 497 2013 67 73
21. H. Li, B. Handsaker, A. Wysoker, T. Fennell, J. Ruan, N. Homer, and et al. The sequence alignment/map format and SAMtools Bioinformatics 25 2009 2078 2079
22. R.A. Nout, V.T. Smit, H. Putter, I.M. Jurgenliemk-Schulz, J.J. Jobsen, L.C. Lutgens, and et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial Lancet 375 2010 816 823
23. Figo Committee on Gynecologic Oncology. FIGO staging for carcinoma of the vulva, cervix, and corpus uteri. Int. J. Gynaecol. Obstet. 2014;125:97-8.
24. P. Morice, A. Leary, C. Creutzberg, N. Abu-Rustum, and E. Darai Endometrial cancer Lancet 2015
25. R. Simon Roadmap for developing and validating therapeutically relevant genomic classifiers J. Clin. Oncol. 23 2005 7332 7341
26. M. Slawski, M. Daumer, and A.L. Boulesteix CMA: a comprehensive bioconductor package for supervised classification with high dimensional data BMC Bioinformatics 9 2008 439
27. R: A Language and Environment for Statistical Computing 2014 R Foundation for Statistical Computing Vienna, Austria at http://www.R-project.org /
28. R. Simon, M.D. Radmacher, K. Dobbin, and L.M. McShane Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification J. Natl. Cancer Inst. 95 2003 14 18
29. E.W. Steyerberg, A.J. Vickers, N.R. Cook, T. Gerds, M. Gonen, N. Obuchowski, and et al. Assessing the performance of prediction models: a framework for traditional and novel measures Epidemiology 21 2010 128 138
30. A. Talhouk, M.K. McConechy, S. Leung, H.H. Li-Chang, J.S. Kwon, N. Melnyk, and et al. A clinically applicable molecular-based classification for endometrial cancers Br. J. Cancer 113 2015 299 310
31. E. Stelloo, R.A. Nout, L.C. Naves, N.T. Ter Haar, C.L. Creutzberg, V.T. Smit, and et al. High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma Gynecol. Oncol. 133 2014 197 204
32. E.R. Fearon, and B. Vogelstein A genetic model for colorectal tumorigenesis Cell 61 1990 759 767
33. S. Jones, W.D. Chen, G. Parmigiani, F. Diehl, N. Beerenwinkel, T. Antal, and et al. Comparative lesion sequencing provides insights into tumor evolution Proc. Natl. Acad. Sci. U. S. A. 105 2008 4283 4288
34. P.C. Nowell The clonal evolution of tumor cell populations Science 194 1976 23 28
35. E.R. Fearon, S.R. Hamilton, and B. Vogelstein Clonal analysis of human colorectal tumors Science 238 1987 193 197
36. C. Kandoth, M.D. McLellan, F. Vandin, K. Ye, B. Niu, C. Lu, and et al. Mutational landscape and significance across 12 major cancer types Nature 502 2013 333 339
37. M. Murtaza, S.J. Dawson, K. Pogrebniak, O.M. Rueda, E. Provenzano, J. Grant, and et al. Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer Nat. Commun. 6 2015 8760
38. W.W. de Leng, C.G. Gadellaa-van Hooijdonk, F.A. Barendregt-Smouter, M.J. Koudijs, I. Nijman, J.W. Hinrichs, and et al. Targeted next generation sequencing as a reliable diagnostic assay for the detection of somatic mutations in tumours using minimal DNA amounts from formalin fixed paraffin embedded material PLoS One 11 2016 e0149405
39. A. Mafficini, E. Amato, M. Fassan, M. Simbolo, D. Antonello, C. Vicentini, and et al. Reporting tumor molecular heterogeneity in histopathological diagnosis PLoS One 9 2014 e104979
40. P.L. Bedard, A.R. Hansen, M.J. Ratain, and L.L. Siu Tumour heterogeneity in the clinic Nature 501 2013 355 364